GlassScriptPhysician profile
Lekha S Deere
NPI 1083025324
$4,682.01
in general payments reported to CMS, 2019-2025
29 companies · $1,310 in 2025
The $1,310 reported for 2025 was more than what 81% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $652 · 2022: $1,199 · 2023: $943 · 2024: $577 · 2025: $1,310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,830.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $632.51 | 2021-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Actelion Pharmaceuticals US, INC. | $629.23 | 2021-2025 | Uptravi, Opsumit |
| Abbvie INC. | $526.31 | 2021-2025 | Avycaz, Teflaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $449.43 | 2021-2025 | Ofev, Jascayd |
| Astrazeneca Pharmaceuticals LP | $356.83 | 2021-2025 | Breztri, Fasenra, Evusheld |
| Pfizer INC. | $270.90 | 2021-2025 | |
| Genzyme Corporation | $247.20 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $225.96 | 2021-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $189.98 | 2022-2023 | Acthar |
| Intuitive Surgical, INC. | $188.20 | 2022-2025 | Da Vinci Surgical System |
| Merck Sharp & Dohme LLC | $139.56 | 2022-2025 | Zerbaxa, Winrevair |
| Amgen INC. | $102.79 | 2025 | Imdelltra (Amg757) |
| Inari Medical, INC. | $93.23 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Verona Pharma, INC. | $76.40 | 2025 | Ohtuvayre |
| Pulmonx Corporation | $72.04 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $70.59 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $64.80 | 2022-2025 | Glassia |
| United Therapeutics Corporation | $45.82 | 2022 | |
| La Jolla Pharmaceutical Company | $43.96 | 2024-2025 | Giapreza |
| Astellas Pharma US INC | $43.71 | 2021-2022 | |
| Insmed, INC. | $37.11 | 2022-2025 | Arikayce |
| Bayer Healthcare Pharmaceuticals INC. | $29.22 | 2022-2023 | |
| Mauna Kea Technologies, INC. | $26.63 | 2024 | |
| Ani Pharmaceuticals, INC. | $25.93 | 2025 | Purified Cortrophin Gel |
| Vapotherm INC | $23.62 | 2022 | |
| Mylan Specialty L.P. | $23.51 | 2024 | Yupelri |
| Janssen Pharmaceuticals, INC | $19.98 | 2023 | Xarelto |
| Grifols USA, LLC | $14.40 | 2023 | Prolastin-C Liquid |
| Teleflex LLC | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lekha Deere listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.